XML 89 R52.htm IDEA: XBRL DOCUMENT v3.19.3
Acquisitions and Other Transactions (Narrative) (Details)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
USD ($)
Aug. 22, 2019
USD ($)
Jul. 29, 2019
USD ($)
Mar. 31, 2019
USD ($)
Feb. 27, 2019
USD ($)
Dec. 01, 2018
USD ($)
Feb. 28, 2018
USD ($)
Sep. 30, 2019
USD ($)
Mar. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Sep. 30, 2019
USD ($)
Dec. 31, 2018
USD ($)
May 28, 2019
USD ($)
Aug. 31, 2018
USD ($)
Business Acquisition [Line Items]                            
Goodwill               $ 9,387.1   $ 9,747.8 $ 9,387.1 $ 9,747.8    
Payment for Contingent Consideration Liability, Financing Activities               20.0            
Upjohn Inc.                            
Business Acquisition [Line Items]                            
Business Acquisition, Percentage of Voting Interests Acquired     43.00%                      
TOBI                            
Business Acquisition [Line Items]                            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables                         $ 29.2  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Property, Plant, and Equipment                         30.0  
Cash consideration               463.0            
Acquired intangible assets, weighted average useful life, in years                     10 years      
Finite-Lived Intangible Assets, Period Increase (Decrease)                 $ 100.0          
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets                         496.7  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets                         555.9  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities                         (54.0)  
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities                         (20.0)  
Payments to Acquire Businesses, Gross               240.0            
Business Acquisition, expected future payments, next twelve months                           $ 130.0
Business Acquisition, expected future payment, year two               93.0            
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net                           91.8
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets                         $ 481.9 $ 574.8
Other drug manufacturers                            
Business Acquisition [Line Items]                            
Acquired intangible assets, weighted average useful life, in years                       5 years    
Other drug manufacturers | Product rights and licenses                            
Business Acquisition [Line Items]                            
Payments To Acquire Collaborative Agreement                   20.0   $ 160.0    
Cash consideration         $ 23.3           $ 30.5 $ 220.0    
Series of Individually Immaterial Business Acquisitions                            
Business Acquisition [Line Items]                            
Cash consideration       $ 64.3   $ 130.9         10.0      
Acquired intangible assets, weighted average useful life, in years                       5 years    
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Financial Assets           $ 130.9                
Europe Segment                            
Business Acquisition [Line Items]                            
Goodwill               4,398.7   4,657.4 4,398.7 $ 4,657.4    
North America Segment                            
Business Acquisition [Line Items]                            
Goodwill               3,282.6   3,507.9 3,282.6 3,507.9    
Rest of World Segment                            
Business Acquisition [Line Items]                            
Goodwill               $ 1,705.8   $ 1,582.5 1,705.8 1,582.5    
Revance                            
Business Acquisition [Line Items]                            
Payments To Acquire Collaborative Agreement   $ 5.0         $ 25.0              
Revance | Maximum                            
Business Acquisition [Line Items]                            
Development Milestone Payments             100.0              
Sales Milestone Payments             $ 225.0              
Fujifilm Kyowa Kirin Biologics                            
Business Acquisition [Line Items]                            
Payments To Acquire Collaborative Agreement                       $ 53.7    
YUPELRI                            
Business Acquisition [Line Items]                            
Payments To Acquire Collaborative Agreement                     $ 18.5      
Scenario, Forecast | Series of Individually Immaterial Business Acquisitions                            
Business Acquisition [Line Items]                            
Cash consideration $ 66.6                          
Pfizer, Inc.                            
Business Acquisition [Line Items]                            
Noncontrolling Interest, Ownership Percentage by Parent     57.00%                      
Upjohn Inc. | Pfizer, Inc.                            
Business Acquisition [Line Items]                            
Payments for Business Separation     $ 12,000.0                      
Product | Upjohn Inc.                            
Business Acquisition [Line Items]                            
Number Of Products     20